MTV – speciallægekursus i samfundsmedicin Den europæiske udvikling på MTV området - EUnetHTA-projektet Nye veje for MTV, 14. september 2007 Finn Børlum.

Præsentationer af emnet: "MTV – speciallægekursus i samfundsmedicin Den europæiske udvikling på MTV området - EUnetHTA-projektet Nye veje for MTV, 14. september 2007 Finn Børlum."— Præsentationens transcript:

1 MTV – speciallægekursus i samfundsmedicin Den europæiske udvikling på MTV området - EUnetHTA-projektet Nye veje for MTV, 14. september 2007 Finn Børlum Kristensen Enhed for MTV, Sundhedsstyrelsen DACEHTA

2 Planlægnings- paradigme MTV-paradigme Beslutnings-domæne inkl. regulering forskningsdomæne Planlægnings spørgsmål MTV- spørgsmål MTV- projekt Sammenfat- tende rapport

3 Disposition DACEHTA EUnetHTA – baggrund EUnetHTA – partnere Formål Opgaver Seneste udviklinger National nytte af EUnetHTA

4 MTV er en international aktivitet DACEHTA undgå unødvendigt dobbeltarbejde bruge og udvikle ”best practice” dele de opgaver, der kan deles tilpasning til nationale/regionale sammenhænge men….. sundhedsplanlægning og - politik er et national/regionalt anliggende

5 EU High Level Group on Medical Services – november 2004 DACEHTA Rapport fra EU kommissionens High level Group, 30. november 2004, konkluderede, at: ”MTV er blevet en politisk prioritet, og der er et tvingende behov for etablering af et permanent europæisk netværk for MTV”

6 Udviklingen i 2005 DACEHTA Januar: DG SANCO Public Health Work Plan 2005 (2006) MTV er et prioriteret område EU Kommissær Kyprianou fremhæver, at : ”det er blevet anerkendt, at det er fornuftigt at etablere et permanent europæisk netværk for MTV….Jeg håber at netværket etableres i år med støtte fra Public Health programmet”

7 European network for HTA, EUnetHTA | www.eunethta.net European network for Health Technology Assessment

8 59 partnere –34 associated partners (nationale/regionale MTV- institutioner, sundhedsministerier, forskningsinstitutioner, internationale institutioner –25 collaborating partners (fx WHO, OECD, Europarådet) 24 EU lande (- Slovakiet) 2 EØS lande (Norge, Island) Schweiz 4 ikke-europæiske lande (Israel, Australien, Canada, USA) EUnetHTA partnere EUnetHTA | European network for Health Technology Assessment | www.eunethta.net

9 Overordnet formål: at etablere et effektivt og permanent europæisk netværk for MTV Strategiske formål: at sikre bedre koordination af MTV-aktiviteter og at udgå dobbeltarbejde → mere effektiv brug af national MTV- ressourcer at øge produktion af MTV og dermed input til beslutningstagning at styrke koblingen mellem MTV og beslutningstagning at støtte lande med begrænset erfaring med MTV Formål I EUnetHTA | European network for Health Technology Assessment | www.eunethta.net

10 To praktiske formål: 1.at skabe en organisatorisk ramme for et permanent netværk for MTV 2.at udvikle praktiske redskaber der kan anvendes inden for rammerne Formål II EUnetHTA | European network for Health Technology Assessment | www.eunethta.net

11 WP1Koordination (EMTV, Danmark) WP2Kommunikation (SBU, Sverige & DAHTA, Tyskland) WP3Evaluering (NOKC, Norge) WP4Kerne MTV (FinOHTA, Finland) WP5Tilpasning af eksisterende MTV’er og Kerne MTV til andre kontekster (NCCHTA, England) WP6Kobling mellem MTV og policy (EMTV, Danmark) WP7Monitorering af kommende teknologier og prioritering af MTV (HAS, Frankrig & LBI@HTA, Østrig) WP8MTV supportsystem i lande uden institutionaliseret MTV Opgaver – EUnetHTA Work Packages (WPs) EUnetHTA | European network for Health Technology Assessment | www.eunethta.net

12 HTA is implemented differently across European countries –  Reduced applicability of foreign reports HTA reports lack a standardised information structure –  Extraction of data from reports may be difficult Attempt to define and standardise elements of an HTA to facilitate shared understanding of HTA and promote the international use of HTA results Only a part of all possible health technologies can be addressed through EUnetHTA models for two types of technologies... but it is a start Two types of core HTA are developed 1)an intervention (example: Drug Eluding Stents) 2)a diagnostic technology (example: Multislice CT of Coranary Arteries) Starting points for Core Model work EUnetHTA | European network for Health Technology Assessment | www.eunethta.net

13 EUnetHTA | European network for Health Technology Assessment | www.eunethta.eu The Common Core of evidence, concepts, and methods Common framework Systematic assessment of Clinical evidence Safety Organisation Economy Societal/ethical issues - using common generic HTA-methodological framework Common core of evidence that can be shared Common taxonomy of HTA concepts Work in progress, not for citation Question / evidence element cards

14 EUnetHTA | European network for Health Technology Assessment | www.eunethta.eu Domain Current use of the technology (implementation level) Description and technical characteristics of technology Safety Effectiveness Costs, economic evaluation Ethical aspects Organisational aspects Social aspects Legal aspects Work in progress, not for citation

15 EUnetHTA | European network for Health Technology Assessment | www.eunethta.eu How does HTA split the onion? Work in progress, not for citation (K. Lampe)

16 EUnetHTA | European network for Health Technology Assessment | www.eunethta.eu Elements are described in further detail in element cards The following information is available in each card: Element ID Domain Topic Issue Clarification Importance Information sources Transferability Reference Relations Status Work in progress, not for citation

17 Develop a toolkit for adapting the “core” that may be shareable in existing HTA reports made for one country into advice appropriate to other contexts (social, political, economic and health system) Produce a glossary of ‘adaptation’ terms WP5: Adapting existing and ‘common’ core HTA EUnetHTA | European network for Health Technology Assessment | www.eunethta.eu

18 Relationship between WP4 and WP5 Policy Questions HTA Questions WP4WP5 A)A1) Common generic HTA-methodological framework based on best practice A2) Common generic HTA-taxonomy DE NOVOADAPTATION OF EXISTING HTA B) Systematic search & review of literature Diagnosis (Screening) and/or Intervention “Natural history of the disease” Relevant economic models Technology/disease specific social and/or ethical issues B) systematic extraction of HTA information from existing HTA report(s) Diagnosis (Screening) and/or Intervention “Natural history of the disease” Identification of relevant economic models Overview of technology/disease specific social and/or ethical issues addressed C1) Methodic assessment of - Epidemiology - Organisation - Economy - Societal/ethical issues using common generic HTA-methodological framework and HTA-taxonomy C2) Reporting to inform policy C1) Application of adaptation toolkit using common generic HTA-methodological framework and HTA- taxonomy C2) Reporting to inform policy INTER / SUPRA-NATIONAL NATIONAL / REGIONAL Work in progress, not for citation

19 Intern EUnetHTA afklaring frem til oktober 2007 Offentlig høringsproces november – december 2007 Samstemning med EU Strategy for Health Services m.v. 2008 EUnetHTA konference, Institute Pasteur, Paris 20. november 2008 EUnetHTA Collaboration 2009+ EUnetHTA | European network for Health Technology Assessment | www.eunethta.net

20 Transparente og sammenlignelige metoder på tværs af europæiske MTV-rapporter Øget produktion som følge af muligheden for at tilpasse udenlandske MTV-rapporter Mulighed for at opnå øgede erfaringer med anvendelsen af MTV på tværs af Europa National nytte af EUnetHTA EUnetHTA | European network for Health Technology Assessment | www.eunethta.net

21 WWW.eunethta.net EUnetHTA | European network for Health Technology Assessment | www.eunethta.net